Chitosan grafted low molecular weight polylactic acid for protein encapsulation and burst effect reduction

Antonio Di Martino, Pavel Kucharczyk, Jiri Zednik, Vladimir Sedlarik

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Chitosan and chitosan-grafted polylactic acid as a matrix for BSA encapsulation in a nanoparticle structure were prepared through a polyelectrolyte complexation method with dextran sulfate. Polylactic acid was synthetized via a polycondensation reaction using the non-metal-based initiator methanesulfonic acid and grafted to the chitosan backbone by a coupling reaction, with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide as the condensing agent. The effect of concentration of the polymer matrix utilized herein on particle diameter, ζ-potential, encapsulation efficiency, and the release kinetic of the model protein bovine serum albumin at differing pH levels was investigated. The influence of pH and ionic strength on the behavior of the nanoparticles prepared was also researched. Results showed that grafting polylactic acid to chitosan chains reduced the initial burst effect in the kinetics of BSA release from the structure of the nanoparticles. Furthermore, a rise in encapsulation efficiency of the bovine serum albumin and diminishment in nanoparticle diameter were observed due to chitosan modification. The results suggest that both polymers actually show appreciable encapsulation efficiency; and release rate of BSA. CS-g-PLA is more suitable than unmodified CS as a carrier for controlled protein delivery.

Original languageEnglish
Pages (from-to)912-921
Number of pages10
JournalInternational Journal of Pharmaceutics
Volume496
Issue number2
DOIs
Publication statusPublished - 30 Dec 2015
Externally publishedYes

Fingerprint

Chitosan
Molecular Weight
Nanoparticles
Bovine Serum Albumin
Proteins
Polymers
Ethyldimethylaminopropyl Carbodiimide
Dextran Sulfate
Osmolar Concentration
Carrier Proteins
poly(lactic acid)

Keywords

  • Bovine serum albumin
  • Chitosan
  • Controlled drug delivery
  • Nanoparticles
  • Polylactic acid

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Chitosan grafted low molecular weight polylactic acid for protein encapsulation and burst effect reduction. / Di Martino, Antonio; Kucharczyk, Pavel; Zednik, Jiri; Sedlarik, Vladimir.

In: International Journal of Pharmaceutics, Vol. 496, No. 2, 30.12.2015, p. 912-921.

Research output: Contribution to journalArticle

@article{fb9d04b5a34f45c8870b83080cde8a80,
title = "Chitosan grafted low molecular weight polylactic acid for protein encapsulation and burst effect reduction",
abstract = "Chitosan and chitosan-grafted polylactic acid as a matrix for BSA encapsulation in a nanoparticle structure were prepared through a polyelectrolyte complexation method with dextran sulfate. Polylactic acid was synthetized via a polycondensation reaction using the non-metal-based initiator methanesulfonic acid and grafted to the chitosan backbone by a coupling reaction, with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide as the condensing agent. The effect of concentration of the polymer matrix utilized herein on particle diameter, ζ-potential, encapsulation efficiency, and the release kinetic of the model protein bovine serum albumin at differing pH levels was investigated. The influence of pH and ionic strength on the behavior of the nanoparticles prepared was also researched. Results showed that grafting polylactic acid to chitosan chains reduced the initial burst effect in the kinetics of BSA release from the structure of the nanoparticles. Furthermore, a rise in encapsulation efficiency of the bovine serum albumin and diminishment in nanoparticle diameter were observed due to chitosan modification. The results suggest that both polymers actually show appreciable encapsulation efficiency; and release rate of BSA. CS-g-PLA is more suitable than unmodified CS as a carrier for controlled protein delivery.",
keywords = "Bovine serum albumin, Chitosan, Controlled drug delivery, Nanoparticles, Polylactic acid",
author = "{Di Martino}, Antonio and Pavel Kucharczyk and Jiri Zednik and Vladimir Sedlarik",
year = "2015",
month = "12",
day = "30",
doi = "10.1016/j.ijpharm.2015.10.017",
language = "English",
volume = "496",
pages = "912--921",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Chitosan grafted low molecular weight polylactic acid for protein encapsulation and burst effect reduction

AU - Di Martino, Antonio

AU - Kucharczyk, Pavel

AU - Zednik, Jiri

AU - Sedlarik, Vladimir

PY - 2015/12/30

Y1 - 2015/12/30

N2 - Chitosan and chitosan-grafted polylactic acid as a matrix for BSA encapsulation in a nanoparticle structure were prepared through a polyelectrolyte complexation method with dextran sulfate. Polylactic acid was synthetized via a polycondensation reaction using the non-metal-based initiator methanesulfonic acid and grafted to the chitosan backbone by a coupling reaction, with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide as the condensing agent. The effect of concentration of the polymer matrix utilized herein on particle diameter, ζ-potential, encapsulation efficiency, and the release kinetic of the model protein bovine serum albumin at differing pH levels was investigated. The influence of pH and ionic strength on the behavior of the nanoparticles prepared was also researched. Results showed that grafting polylactic acid to chitosan chains reduced the initial burst effect in the kinetics of BSA release from the structure of the nanoparticles. Furthermore, a rise in encapsulation efficiency of the bovine serum albumin and diminishment in nanoparticle diameter were observed due to chitosan modification. The results suggest that both polymers actually show appreciable encapsulation efficiency; and release rate of BSA. CS-g-PLA is more suitable than unmodified CS as a carrier for controlled protein delivery.

AB - Chitosan and chitosan-grafted polylactic acid as a matrix for BSA encapsulation in a nanoparticle structure were prepared through a polyelectrolyte complexation method with dextran sulfate. Polylactic acid was synthetized via a polycondensation reaction using the non-metal-based initiator methanesulfonic acid and grafted to the chitosan backbone by a coupling reaction, with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide as the condensing agent. The effect of concentration of the polymer matrix utilized herein on particle diameter, ζ-potential, encapsulation efficiency, and the release kinetic of the model protein bovine serum albumin at differing pH levels was investigated. The influence of pH and ionic strength on the behavior of the nanoparticles prepared was also researched. Results showed that grafting polylactic acid to chitosan chains reduced the initial burst effect in the kinetics of BSA release from the structure of the nanoparticles. Furthermore, a rise in encapsulation efficiency of the bovine serum albumin and diminishment in nanoparticle diameter were observed due to chitosan modification. The results suggest that both polymers actually show appreciable encapsulation efficiency; and release rate of BSA. CS-g-PLA is more suitable than unmodified CS as a carrier for controlled protein delivery.

KW - Bovine serum albumin

KW - Chitosan

KW - Controlled drug delivery

KW - Nanoparticles

KW - Polylactic acid

UR - http://www.scopus.com/inward/record.url?scp=84949580204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949580204&partnerID=8YFLogxK

U2 - 10.1016/j.ijpharm.2015.10.017

DO - 10.1016/j.ijpharm.2015.10.017

M3 - Article

VL - 496

SP - 912

EP - 921

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

IS - 2

ER -